Brought to you by 
Concordia International raises $350mm in senior note financing
15 Nov 2016
Executive Summary
Concordia International Corp. (specialty pharma and generics) raised $350mm through the sale of five-and-a-half year 9% senior secured first lien notes. The company will use the proceeds to fund pipeline projects and for small regional product acquisitions.
Deal Industry
- Medical Devices
- Pharmaceuticals
-
Pharmaceuticals
- Generic Drugs
- Specialty Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- Nonconvertible Debt
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Concordia International raises $350mm in senior note financing
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice